SCHEMBL6168967

SCHEMBL6168967

CN(C)C(=O)c1onc2cc(Br)ccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.43
RAB9A P51151 4/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
LMNA P02545 2/20 0.39
NCEH1 Q6PIU2 3/20 0.37
POLB P06746 1/20 0.36
TP53 P04637 2/20 0.36
NPC1 O15118 1/20 0.36
MAPK1 P28482 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.34
KMT2A Q03164 3/20 0.34
MEN1 O00255 2/20 0.34
RECQL P46063 1/20 0.33
MAPT P10636 2/20 0.33
SLC22A12 Q96S37 1/20 0.33
KDM4E B2RXH2 1/20 0.33
HTT P42858 1/20 0.33
PDGFRA P16234 1/20 0.33
CDK5 Q00535 1/20 0.33
TYRO3 Q06418 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17454396 0.83 ALDH1A1 (0.40) ALDH1A1RAB9ASMN1; SMN2TP53L3MBTL1
SCHEMBL17438051 0.81 PTPN1 (0.42) ALDH1A1SMN1; SMN2POLBTP53NPC1
SCHEMBL17437997 0.79 MAPT (0.48) ALDH1A1RAB9APOLBTP53L3MBTL1
SCHEMBL17452805 0.79 PPARA (0.37) ALDH1A1RAB9ASMN1; SMN2LMNATP53
SCHEMBL6168162 0.79 RXFP1 (0.40) ALDH1A1RAB9ASMN1; SMN2LMNATP53
SCHEMBL6170975 0.78 RAB9A (0.43) ALDH1A1RAB9ASMN1; SMN2LMNAPOLB
SCHEMBL3526936 0.76 ALDH1A1 (0.46) ALDH1A1RAB9ASMN1; SMN2LMNANCEH1
SCHEMBL3635258 0.75 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2LMNAMAPK1MAPT
SCHEMBL25171030 0.75 RAB9A (0.38) ALDH1A1RAB9ASMN1; SMN2LMNANCEH1
SCHEMBL6169856 0.73 RAB9A (0.53) ALDH1A1RAB9ASMN1; SMN2LMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1531812-A1 FUSED HETEROARYL DERIVATIVES FOR USE AS P38 KINASE INHIBITORS IN THE TREATMENT OF I.A. RHEUMATOID ARTHRISTIS SMITHKLINE BEECHAM CORPORATION (US) 2005-05-25 EP disclosed
WO-2004010995-A1 FUSED HETEROARYL DERIVATIVES FOR USE AS P38 KINASE INHIBITORS IN THE TREATMENT OF I.A. RHEUMATOID ARTHRISTIS SMITHKLINE BEECHAM CORPORATION (US) 2004-02-05 WO disclosed